Literature DB >> 25100286

[Orthopedic management of spina bifida].

R Biedermann1.   

Abstract

BACKGROUND: Spina bifida is associated with congenital deformities, such as kyphosis, spinal malformations, teratological hip dislocations, clubfeet, vertical talus and also with acquired deformities due to muscle imbalance and impaired biomechanics. The degree of the acquired deformities and the mobility of the patient depend on the level of the spinal lesion. DIAGNOSTICS: Neurological symptoms are mostly asymmetric and there is an inconsistent correlation between the anatomical level of the lesion and muscle function. Deficits of sensation are usually one to two levels lower than the motor level. An exact neurological diagnosis should not be made before the second or third year of life and an early prognosis about walking ability should be avoided. The level L3 and therefore function of the quadriceps is a functional milestone after which modified independent ambulation with the use of ankle foot orthoses (AFO) and crutches is possible. THERAPY: The basic principle is to support verticalization and gait even when loss of ambulation is later expected. It is also important to support and maintain sitting ability for high lesions, if necessary with correction of the spinal deformity. Findings in gait analysis have shifted the focus of treatment from radiological criteria to functional improvement, thus maintenance of the flexibility of the hip is the main goal of hip surgery. Reduction of the hip often leads to stiffness and has a high redislocation rate. Clubfoot deformities should be treated early and foot arthrodesis and stiffness have to be avoided. Another focus is the prevention of joint contracture by early prophylactic treatment.
CONCLUSION: The purpose of management is to maximize the functional potential of the child. Subjective well-being, absence of pain, mobility and socialization are the main goals. This does not necessarily imply ambulation; nevertheless, verticalization and associated orthotic management is one major objective of the orthopedic management of spina bifida.

Entities:  

Mesh:

Year:  2014        PMID: 25100286     DOI: 10.1007/s00132-013-2215-9

Source DB:  PubMed          Journal:  Orthopade        ISSN: 0085-4530            Impact factor:   1.087


  20 in total

1.  THE SEGMENTAL INNERVATION OF THE LOWER LIMB MUSCLES IN MAN.

Authors:  W J SHARRARD
Journal:  Ann R Coll Surg Engl       Date:  1964-08       Impact factor: 1.891

2.  Neonatal assessment of the child with a myelomeningocele.

Authors:  G D Stark
Journal:  Arch Dis Child       Date:  1971-08       Impact factor: 3.791

Review 3.  What variables influence the ability of an AFO to improve function and when are they indicated?

Authors:  Bryan S Malas
Journal:  Clin Orthop Relat Res       Date:  2011-05       Impact factor: 4.176

4.  Crouched gait in myelomeningocele: a comparison between the degree of knee flexion contracture in the clinical examination and during gait.

Authors:  Todd Moen; Nicholas Gryfakis; Luciano Dias; Laura Lemke
Journal:  J Pediatr Orthop       Date:  2005 Sep-Oct       Impact factor: 2.324

5.  Anterior femoral epiphysiodesis for the treatment of fixed knee flexion deformity in spina bifida patients.

Authors:  Alexander S Spiro; Kornelia Babin; Sandra Lipovac; Martin Rupprecht; Norbert M Meenen; Johannes M Rueger; Ralf Stuecker
Journal:  J Pediatr Orthop       Date:  2010-12       Impact factor: 2.324

6.  A randomized trial of prenatal versus postnatal repair of myelomeningocele.

Authors:  N Scott Adzick; Elizabeth A Thom; Catherine Y Spong; John W Brock; Pamela K Burrows; Mark P Johnson; Lori J Howell; Jody A Farrell; Mary E Dabrowiak; Leslie N Sutton; Nalin Gupta; Noel B Tulipan; Mary E D'Alton; Diana L Farmer
Journal:  N Engl J Med       Date:  2011-02-09       Impact factor: 91.245

7.  Function of dislocated hips in children with lower level spina bifida.

Authors:  B A Alman; M Bhandari; J G Wright
Journal:  J Bone Joint Surg Br       Date:  1996-03

8.  Grice arthrodesis in the treatment of valgus feet in children with myelomeningocele: a 12.8-year follow-up study.

Authors:  Per Reidar Høiness; Eva Kirkhus
Journal:  J Child Orthop       Date:  2009-06-16       Impact factor: 1.548

9.  Neuropathic foot ulceration in patients with myelodysplasia.

Authors:  M J Maynard; L S Weiner; S W Burke
Journal:  J Pediatr Orthop       Date:  1992 Nov-Dec       Impact factor: 2.324

10.  Orthopedic management of spina bifida. Part I: hip, knee, and rotational deformities.

Authors:  Vineeta T Swaroop; Luciano Dias
Journal:  J Child Orthop       Date:  2009-10-25       Impact factor: 1.548

View more
  2 in total

1.  The relationship between the level of lesion and progression in Reimer's index of spina bifida patients.

Authors:  Huseyin Gunay; Murat Celal Sozbilen; Mahmut Altınisik; Ismail Eralp Kacmaz; Elcil Kaya Bicer
Journal:  Childs Nerv Syst       Date:  2016-10-27       Impact factor: 1.475

Review 2.  Orthopedic management of myelomeningocele with a multidisciplinary approach: a systematic review of the literature.

Authors:  Ana Presedo; Amirali Karimi; Parnian Shobeiri; Sara Momtazmanesh; Fardis Vosoughi; Mohammad Hossein Nabian
Journal:  J Orthop Surg Res       Date:  2021-08-13       Impact factor: 2.359

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.